U.S. cancer survival has reached a historic high: about 70% of people now live at least five years after a cancer diagnosis, even as more Americans are being diagnosed and overall deaths continue to fall. A recent Bloomberg piece is essentially reporting key findings from the American Cancer Society’s new 2026 statistics release.
Key numbers
- About 2.1 million new cancer diagnoses and roughly 626,000 cancer deaths are projected in the U.S. in 2026.
- The five‑year relative survival rate for all cancers combined is now 70% for people diagnosed during 2015–2021, up from about 50% in the mid‑1970s.
- The overall U.S. cancer mortality rate has fallen about 34% since its peak around 1991, preventing an estimated 4.8 million deaths through 2023.
Why survivors are increasing
- Better treatments (targeted drugs, immunotherapy, and optimized combinations of surgery, radiation, and systemic therapy) have sharply improved outcomes in cancers once seen as near‑uniformly fatal, such as lung cancer, myeloma, and liver cancer.
- Earlier detection through screening (e.g., mammography, colonoscopy, low‑dose CT for some smokers) and greater awareness mean more cancers are found at stages where cure or long‑term control is more likely.
- Behavioral shifts, particularly reduced smoking, have cut risk for lung and several other cancers and contributed significantly to the long‑run drop in mortality.
Where the progress is strongest
- Five‑year survival for distant‑stage (metastatic) cancers overall has doubled since the mid‑1990s, from about 17% to 35%.
- Survival has improved markedly for:
Ongoing problems and disparities
- Incidence is rising for several common cancers, including breast, prostate, female liver cancer, melanoma in women, oral cavity, pancreatic, and endometrial cancers.
- Lung cancer remains the leading cause of cancer death and is expected to kill more people in 2026 than colorectal and pancreatic cancers combined.
- Native American people have the highest cancer mortality, with death rates roughly twice those of White people for kidney, liver, stomach, and cervical cancers, underscoring major inequities in prevention and care.
Big‑picture takeaway
- The U.S. is simultaneously seeing more people living with or beyond cancer (nearly 19 million survivors, and growing) and a continuing long‑term decline in the risk of dying from cancer at a given age.
- Longevity creates a dual reality: improving therapies and detection are converting many cancers into chronic, manageable diseases, but they also create growing needs around survivorship care, financial toxicity, and closing persistent gaps by race, geography, and socioeconomic status.
